Market Closed -
Bombay S.E.
06:00:58 2024-06-14 EDT
|
5-day change
|
1st Jan Change
|
423.9
INR
|
-1.02%
|
|
+13.74%
|
+88.11%
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
428.5
|
205.8
|
83.64
|
210.8
|
351.3
|
650.7
|
Enterprise Value (EV)
1 |
1,474
|
1,030
|
817.3
|
1,062
|
1,203
|
1,551
|
P/E ratio
|
16.1
x
|
-3.2
x
|
-13.8
x
|
14.5
x
|
10.4
x
|
5.05
x
|
Yield
|
1.56%
|
-
|
-
|
-
|
-
|
1.71%
|
Capitalization / Revenue
|
0.09
x
|
0.05
x
|
0.02
x
|
0.07
x
|
0.07
x
|
0.07
x
|
EV / Revenue
|
0.3
x
|
0.23
x
|
0.24
x
|
0.33
x
|
0.24
x
|
0.18
x
|
EV / EBITDA
|
13.9
x
|
42.4
x
|
20.8
x
|
16
x
|
10.8
x
|
5.43
x
|
EV / FCF
|
-4.06
x
|
4.3
x
|
9.61
x
|
-7.4
x
|
-58.6
x
|
-21
x
|
FCF Yield
|
-24.6%
|
23.2%
|
10.4%
|
-13.5%
|
-1.71%
|
-4.77%
|
Price to Book
|
1.04
x
|
0.6
x
|
0.25
x
|
0.6
x
|
0.91
x
|
1.26
x
|
Nbr of stocks (in thousands)
|
5,576
|
5,576
|
5,576
|
5,576
|
5,576
|
5,576
|
Reference price
2 |
76.85
|
36.90
|
15.00
|
37.80
|
63.00
|
116.7
|
Announcement Date
|
18-09-03
|
19-08-18
|
20-08-25
|
21-08-25
|
22-09-05
|
23-08-26
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
4,856
|
4,537
|
3,469
|
3,180
|
4,978
|
8,744
|
EBITDA
1 |
105.8
|
24.3
|
39.24
|
66.24
|
111.6
|
285.5
|
EBIT
1 |
91.85
|
9.233
|
24.09
|
52.14
|
96.43
|
269.5
|
Operating Margin
|
1.89%
|
0.2%
|
0.69%
|
1.64%
|
1.94%
|
3.08%
|
Earnings before Tax (EBT)
1 |
45.8
|
-64.3
|
-15.33
|
17.61
|
31.95
|
171.7
|
Net income
1 |
26.69
|
-64.28
|
-6.05
|
14.49
|
33.71
|
128.9
|
Net margin
|
0.55%
|
-1.42%
|
-0.17%
|
0.46%
|
0.68%
|
1.47%
|
EPS
2 |
4.787
|
-11.53
|
-1.090
|
2.599
|
6.046
|
23.12
|
Free Cash Flow
1 |
-362.9
|
239.3
|
85
|
-143.6
|
-20.51
|
-73.99
|
FCF margin
|
-7.47%
|
5.27%
|
2.45%
|
-4.52%
|
-0.41%
|
-0.85%
|
FCF Conversion (EBITDA)
|
-
|
984.84%
|
216.65%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
1.200
|
-
|
-
|
-
|
-
|
2.000
|
Announcement Date
|
18-09-03
|
19-08-18
|
20-08-25
|
21-08-25
|
22-09-05
|
23-08-26
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1,045
|
824
|
734
|
852
|
851
|
901
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
9.878
x
|
33.92
x
|
18.7
x
|
12.85
x
|
7.625
x
|
3.154
x
|
Free Cash Flow
1 |
-363
|
239
|
85
|
-144
|
-20.5
|
-74
|
ROE (net income / shareholders' equity)
|
6.69%
|
-17%
|
-1.79%
|
4.21%
|
9.12%
|
28.6%
|
ROA (Net income/ Total Assets)
|
3.89%
|
0.37%
|
1.09%
|
2.42%
|
4.29%
|
10.8%
|
Assets
1 |
685.5
|
-17,436
|
-554.2
|
598.3
|
786
|
1,198
|
Book Value Per Share
2 |
74.10
|
61.30
|
60.20
|
63.20
|
69.30
|
92.40
|
Cash Flow per Share
2 |
0.1900
|
4.320
|
0.0500
|
0.0400
|
0.8200
|
0.0200
|
Capex
1 |
19.2
|
23.6
|
3.25
|
11.8
|
11.5
|
11.9
|
Capex / Sales
|
0.39%
|
0.52%
|
0.09%
|
0.37%
|
0.23%
|
0.14%
|
Announcement Date
|
18-09-03
|
19-08-18
|
20-08-25
|
21-08-25
|
22-09-05
|
23-08-26
|
|
1st Jan change
|
Capi.
|
---|
| +88.11% | 28.29M | | +0.07% | 98.24B | | -10.90% | 58.77B | | +63.33% | 45.23B | | +12.56% | 37.42B | | -1.62% | 30.46B | | +7.05% | 19.26B | | +11.98% | 16.67B | | +6.45% | 13.6B | | -6.76% | 12.73B |
Other Commodity Chemicals
|